search
Back to results

The Impact of Air Filtration on Asthmatic Children

Primary Purpose

Asthma in Children

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Bedroom air filtered by an air filtration device to remove airborne pollutants
Sponsored by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Asthma in Children focused on measuring asthma, air pollution, air filtration, indoor air quality, respiratory health

Eligibility Criteria

5 Years - 14 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

An eligible child is defined as:

  • Aged between 5 and 14
  • Have physician-diagnosed asthma
  • Had at least one asthma attack during the past year

An eligible household is defined as:

  • Has an eligible child
  • Located in Shanghai, China

Exclusion Criteria:

  • Children who were current smokers or have diseases other than asthma are exclude from study participation

Sites / Locations

  • Shanghai General Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Bedroom air filtered by an air filtration device

Bedroom air filtered by a placebo air filtration device

Arm Description

The air in the bedroom of study subjects in the active comparator arm was filtered by an air filtration device which processed air through a pre-filter, a high efficiency particular air (HEPA) filter and an active carbon filter. The duration of being in the active comparator arm was 2 weeks.

The air in the bedroom of subjects in the placebo arm was filtered by a placebo air filtration device that looked identical to the real air filtration device but did not possess the HEPA filter and the active carbon filter. The duration of being in the placebo arm was 2 weeks.

Outcomes

Primary Outcome Measures

Fractional exhaled nitric oxide (FeNO)
Fractional exhaled nitric oxide (FeNO) was measured using the NIOX machine

Secondary Outcome Measures

Asthma symptoms
Asthma symptom was evaluated by the Asthma Control Test (ACT) questionnaire
Peak expiratory flow (PEF)
The maximum speed of exhalation (PEF) was measured by a handheld PEF meter (Koka Peak Expiratory Flow Meter)
Lung function
Lung function was assessed by spirometry (Jaeger MasterScreen™ PFT system) and impulse oscillometry (Jaeger MasterScreenTM IOS).

Full Information

First Posted
August 24, 2017
Last Updated
March 19, 2020
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators
Underwriters Laboratory, Inc, Duke University, Tsinghua University, University of Wisconsin, Madison
search

1. Study Identification

Unique Protocol Identification Number
NCT03282864
Brief Title
The Impact of Air Filtration on Asthmatic Children
Official Title
The Impact of Air Filtration on Health Indicators of Asthmatic Children
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
January 17, 2017 (Actual)
Primary Completion Date
April 22, 2017 (Actual)
Study Completion Date
December 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators
Underwriters Laboratory, Inc, Duke University, Tsinghua University, University of Wisconsin, Madison

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study uses a crossover study design to examine the impact of a two-week bedroom based indoor air filtration on the concentration of indoor airborne pollutants, personal exposure to airborne pollutants and health indicators among asthmatic children living in Shanghai, China
Detailed Description
This study recruited asthmatic children aged 5 to 14 who were living in Shanghai, China. Every study subject had the air in their bedroom processed by an air filtration device (with a pre-filter, a HEPA filter and an active carbon filter) for two weeks (active comparator arm), processed by a placebo air filtration device (which did not possess the HEPA filter and active carbon filters) for two weeks (placebo arm), and underwent a two-week washout period (no use of air filtration device) between the two intervention periods. The doors and windows of the bedroom were instructed to be kept closed during the intervention periods. The sequence of being in the active comparator arm and the placebo arm was randomized for each subject. The subject, their guardian and researchers who have direct interaction with the study subjects do not know this sequence until after the end of the study. The study protocol was approved by IRB at Shanghai First People's Hospital, Duke University and University of Wisconsin at Madison. A sample size of 40 was calculated using fractional exhaled nitric oxide (FeNO) as the primary outcome where statistical significance was set at 0.05, power at 90%, and between-subject variance and covariance were estimated from existing literature. Four additional subjects were added to the estimated sample size of 40 to account for potential dropouts. Subjects were recruited from patients who attended the outpatient clinic of the Pediatrics Department of Shanghai First People's Hospital (south section) by Dr. Zhen Li and Dr. Junfeng Zhang's team. Assent was obtained from all study subjects and written informed consent was obtained from their guardians. During the study, Dr. Michael Bergin's team and Dr. Yinping Zhang's team installed the air filtration devices in the subject's bedroom and measured the indoor concentration, outdoor concentration and personal exposure to airborne pollutants including PM2.5, ozone and volatile organic compounds. Dr. James Schauer's team analyzed the physical, chemical and bioactivity of the airborne particles collected and had no direct contact with the study subjects. Each subject attended 5 clinical visits at the Shanghai First People's Hospital (South Section) accompanied by their guardian where clinical assessment (of lung function, fractional exhaled nitric oxide, asthma symptom blood draw) was performed by Drs. Zhen Li and Feng Li's team, and the collection of biological media (urine, saliva and nasal fluid) was conducted by Dr. Junfeng (Jim) Zhang's team. In addition, subjects were instructed to measure the peak expiratory flow (PEF) at 7am and 9pm daily and recorded their asthma symptoms at home with the assistance from their guardian(s). The biological media (urine, saliva and nasal fluid) collected was subsequently analyzed by Dr. Junfeng (Jim) Zhang's team for health indicators. Each subject had access to the result of clinical assessment and health indicator in biological media, as well as free consultation from the medical teams of Drs. Zhen Li and Feng Li. Every subject was remunerated with 1000RMB (equivalent to 152 US dollars) and given a peak expiratory flow meter (worth less than 10 US dollars). All information collected from study subjects were recorded under their subject ID number and kept confidential. Only de-identified data was shared between collaborating investigators. Statistical analysis including mixed-effects models will be conducted on the data collected.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma in Children
Keywords
asthma, air pollution, air filtration, indoor air quality, respiratory health

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Every study subject had the air in their bedroom processed by an air filtration device (with a pre-filter, a HEPA filter and an active carbon filter) for two weeks (active comparator arm), processed by a placebo air filtration device (which did not possess the HEPA filter and active carbon filters) for two weeks (placebo arm), and underwent a two-week washout period (no use of air filtration device) between the two intervention periods.
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
The real air filtration device and the placebo air filtration device looked identical, however the placebo air filtration device lacked the HEPA and active carbon filters which functioned to remove airborne pollutants.
Allocation
Randomized
Enrollment
43 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Bedroom air filtered by an air filtration device
Arm Type
Active Comparator
Arm Description
The air in the bedroom of study subjects in the active comparator arm was filtered by an air filtration device which processed air through a pre-filter, a high efficiency particular air (HEPA) filter and an active carbon filter. The duration of being in the active comparator arm was 2 weeks.
Arm Title
Bedroom air filtered by a placebo air filtration device
Arm Type
Placebo Comparator
Arm Description
The air in the bedroom of subjects in the placebo arm was filtered by a placebo air filtration device that looked identical to the real air filtration device but did not possess the HEPA filter and the active carbon filter. The duration of being in the placebo arm was 2 weeks.
Intervention Type
Device
Intervention Name(s)
Bedroom air filtered by an air filtration device to remove airborne pollutants
Intervention Description
The air in the bedroom of study subjects in the active comparator arm was processed by an air filtration device which pulled air through a pre-filter, a high efficiency particular air (HEPA) filter and an active carbon filter continuously. The air in the bedroom of subjects in the placebo arm was processed by a placebo air filtration device that looked identical to the real air filtration device but did not possess the HEPA filter and the active carbon filter. Each subject was assigned to the active comparator arm and the placebo arm in a randomized order with a two-week washout period scheduled in-between. The subjects, their guardians and the study staff that assessed the health indicators of the subjects were blinded to this order till the end of the study.
Primary Outcome Measure Information:
Title
Fractional exhaled nitric oxide (FeNO)
Description
Fractional exhaled nitric oxide (FeNO) was measured using the NIOX machine
Time Frame
Change of FeNO after the end of the two-week intervention compared to the start of the two-week intervention period
Secondary Outcome Measure Information:
Title
Asthma symptoms
Description
Asthma symptom was evaluated by the Asthma Control Test (ACT) questionnaire
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Title
Peak expiratory flow (PEF)
Description
The maximum speed of exhalation (PEF) was measured by a handheld PEF meter (Koka Peak Expiratory Flow Meter)
Time Frame
Measured at 7am and 9pm daily during the two-week intervention
Title
Lung function
Description
Lung function was assessed by spirometry (Jaeger MasterScreen™ PFT system) and impulse oscillometry (Jaeger MasterScreenTM IOS).
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Other Pre-specified Outcome Measures:
Title
Malondialdehyde (MDA) concentration in urine
Description
Malondialdehyde (MDA) concentration in urine was measured using the thiobarbituric acid derivatization method and high-performance liquid chromatography (HPLC)
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Title
8-OHdG concentration in urine
Description
Concentration of 8-hydroxydeoxyguanosine (8-OHdG) in urine was measured by solid phase extraction and liquid chromatography-mass spectrometry (LC-MS)
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Title
Malondialdehyde (MDA) concentration in nasal fluid
Description
Malondialdehyde (MDA) concentration in nasal fluid was measured using the thiobarbituric acid derivatization method and high-performance liquid chromatography (HPLC)
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Title
Malondialdehyde (MDA) concentration in saliva
Description
Malondialdehyde (MDA) concentration in saliva was measured using the thiobarbituric acid derivatization method and high-performance liquid chromatography (HPLC)
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Title
Interleukin-6 level in saliva
Description
The concentration of interleukin-6 in saliva was measured by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Title
Eosinophil cationic protein concentration in saliva
Description
The concentration of eosinophil cationic protein in saliva was measured by enzyme-linked immunosorbent assay (ELISA)
Time Frame
Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Title
Blood eosinophil
Description
Blood eosinophil was assessed using the blood routine test
Time Frame
Only once at the time of enrollment into the study
Title
Allergen profile
Description
The IgE antibody for 19 allergens were assessed using serum samples from study subjects.
Time Frame
Only once at the time of enrollment into the study
Title
Chemical exposure
Description
Personal exposure to chemicals including flame retardant and organophosphates was assessed using silicone wristbands that were worn on the wrist of study subjects for 1 week
Time Frame
During 1 week of the study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: An eligible child is defined as: Aged between 5 and 14 Have physician-diagnosed asthma Had at least one asthma attack during the past year An eligible household is defined as: Has an eligible child Located in Shanghai, China Exclusion Criteria: Children who were current smokers or have diseases other than asthma are exclude from study participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael H. Bergin, PhD
Organizational Affiliation
Duke University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Junfeng Zhang, PhD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
James J. Schauer, PhD
Organizational Affiliation
University of Wisconsin, Madison
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yinping Zhang, PhD
Organizational Affiliation
Tsinghua University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Feng Li, MD
Organizational Affiliation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shanghai General Hospital
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
201620
Country
China

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
32250418
Citation
Cui X, Li Z, Teng Y, Barkjohn KK, Norris CL, Fang L, Daniel GN, He L, Lin L, Wang Q, Day DB, Zhou X, Hong J, Gong J, Li F, Mo J, Zhang Y, Schauer JJ, Black MS, Bergin MH, Zhang J. Association Between Bedroom Particulate Matter Filtration and Changes in Airway Pathophysiology in Children With Asthma. JAMA Pediatr. 2020 Jun 1;174(6):533-542. doi: 10.1001/jamapediatrics.2020.0140.
Results Reference
derived
PubMed Identifier
31753466
Citation
Brehmer C, Norris C, Barkjohn KK, Bergin MH, Zhang J, Cui X, Teng Y, Zhang Y, Black M, Li Z, Shafer MM, Schauer JJ. The impact of household air cleaners on the oxidative potential of PM2.5 and the role of metals and sources associated with indoor and outdoor exposure. Environ Res. 2020 Feb;181:108919. doi: 10.1016/j.envres.2019.108919. Epub 2019 Nov 13.
Results Reference
derived

Learn more about this trial

The Impact of Air Filtration on Asthmatic Children

We'll reach out to this number within 24 hrs